The overall goal for this R34 is to produce a culturally adapted, scalable HIV 'status-neutral' EBI for alcohol reduction and HIV prevention and treatment optimization to test in an R01 hybrid effectiveness-implementation trial. We will conduct a 2-arm pilot randomized controlled trial (RCT) comparing TrEAT4All to usual care to assess the preliminary efficacy and implementation of HIV prevention and treatment within one STI care setting which serves as an early Pre-exposure Prophylaxis (PrEP) implementation site in Lilongwe, Malawi.
Wake Forest University School of Medicine Team
Co-Principal Investigator, Department of Implementation Science
Angela Parcesepe, PhD, MPH, Co-Principal Investigator, Department of Maternal and Child Health, University of North Carolina at Chapel Hill
Mitch Matoga, Co-Investigator, UNC Project Malawi
Agatha Bula, Co-Investigator
Jimmy Msola, Co-Investigator
Eric Umar, Co-Investigator, KHuES
Judith Hahn, UCSF
Jessica Magidson, Co-Investigator, University of Maryland
Jaslyn Grullon
Jaelyn Murphy